Quick Menu

Upcoming Journals

Journal of Pharmaceutical Research International

Journal of Pharmaceutical Research International, ISSN: 2456-9119, ISSN: 2231-2919 (past),Vol.: 20, Issue.: 1

Original-research-article

QSAR Pharmacophore-based Virtual Screening, CoMFA and CoMSIA Modeling and Molecular Docking towards Identifying Lead Compounds for Breast Cancer Protease Inhibitors

 

Lan Huang1, Xuan R. Zhang1*, Pei H. Luo1, Lun Yuan2, Xang Z. Zhou2, X. Gao1 and Ling S. Li2

1School of Chemical Engineering, Sichuan University, Chengdu 610065, China.

2Department of Pharmaceutical Engineering, Sichuan University, Chengdu 610041, China.

 

Article Information
Editor(s):
(1) Syed A. A. Rizvi, Department of Pharmaceutical Sciences, College of Pharmacy, Nova Southeastern University, USA.
Reviewers:
(1) Mohamed Ahmed Mohamed Nagy Mohamed, Beni-Suef University, Egypt.
(2) Fatma Kandemirli, Kastamonu University, Turkey.
Complete Peer review History: http://www.sciencedomain.org/review-history/22232

 

Abstracts

 

Aim: This study used QSAR Pharmacophore-based virtual screening and molecular docking to identify lead compounds and determine structural requirements for breast cancer inhibitor development. CoMFA and CoMSIA modeling was employed to design more potential inhibitors.

Materials and Methods: 3D-QSAR pharmacophore models were developed using HypoGen Module and validated by Fischer’s model and decoy test. The best pharmacophore model was employed to screen ZINC chemical library to obtain reasonable hits. Following ADMET filtering, 18 hits were subjected to further filter through docking. CoMFA and CoMSIA models were built by partial least squares on phenylindole-3-carbaldehydes derivatives.

Results: 19 random runs from Fischer’s validation and decoy test which led to an enrichment factor of 48.23 and Guner-Henry factor of 0.774 show that the identified pharmacophore model is highly predictive. Top three hits (IC50=0.01~0.05 µM, fitness =52~62) were identified as potential inhibitory candidates from virtual screening and docking, and three new lead compounds were designed with predicted inhibiting potencies by pIC50 value of 8.55 from CoMFA and CoMSIA modeling and fitness value of ~59 from docking.

Conclusion: Validation results and decoy test indicate that the developed pharmacophore model is highly predictive. Residue Sep6 and Cys 5 were observed as important active sites for ligand-protein binding. Top three hits were identified as more potential inhibitors, and the designed compounds show more inhibiting potencies. The QSAR and docking results obtained from this work should be useful in determining structural requirements for inhibitor development as well as in designing more potential inhibitors.

 

Keywords :

Molecular docking; pharmacophore; bioinformatics; QSAR; comparative molecular field analysis.

 

Full Article - PDF    Page 1-10    Article Metrics

 

DOI : 10.9734/JPRI/2017/37821

Review History    Comments

Search this site

Advanced Search

Announcement & News

ISI Thomson Reuters selected British Journal of Pharmaceutical Research for Emerging Sources Citation Index

We are delighted to inform that ISI Thomson Reuters selected British Journal of Pharmaceutical Resea...

SCOPUS selected Annual Research & Review in Biology (ARRB)

We are delighted to inform that famous indexing organization SCOPUS (from Elsevier) selected  A...

Index Copernicus Evaluation Result Released

We are delighted to inform that Index Copernicus (a leading indexing organization from Pol...

Journal Repository (JR): Permanent Digital Archiving of SDI journals

SDI is happy to announce that all our journals are now permanently archived in Journal Repository (J...

SDI journal got 35th ranking in Publons

We are delighted to announce (as of 04/01/2016) that British Journal of Medicine and Medical Re...

Growth of SDI and world publication market

As of 2014, total 25,064 journals are competing in World market of journal publication. In 2011, tot...

Science (IF: 31) report confirmed the high standard of SDI journal

As per a recent report (Link) of Science journal (present Impact factor 31), one of our journal (Bri...

SDI introduced Post-publication peer review by its comment section

SDI journals encourage Post-publication peer review by its comment section   Policy details a...

SDI promotes transparent Advanced OPEN peer review

We have migrated to transparent and toughest ‘Advanced OPEN peer review’ system (...



SCIENCEDOMAIN Awards

  • No Awards listed.

Browser Compatibility : Mozila firefox, Google Crome and IE 7 & above. Creative Commons License Terms & Condition   |   Privacy Policy   |   Join Us   |   Help   |   Contact Us
© Copyright 2010-2018, SCIENCEDOMAIN international. All rights reserved.